Peptidyl-arginine deiminase-type IV as a diagnostic and prognostic marker in rheumatoid arthritis patients
Aim of the work: To measure serum peptidyl arginine deiminase (PADI4) enzyme level in rheumatoid arthritis (RA) patients and to assess its role in diagnosis and monitoring patient improvement. Patients and methods: The study included 31 RA patients and 10 age and sex matched healthy controls. Serum...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-04-01
|
| Series: | Egyptian Rheumatologist |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1110116418300875 |